Pharmacogenomic importance of pravastatin

B.J.M. Peters; A.H. Maitland-van der Zee

Pharmacogenomic importance of pravastatin

B.J.M. Peters
, A.H. Maitland-van der Zee

Dept of Pharmaceutical Sciences

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1207-1210
Number of pages	4
Journal	Pharmacogenomics
Volume	9
Issue number	9
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

@article{f8e63399ef764f1e905f52ce24e4da6d,

title = "Pharmacogenomic importance of pravastatin",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "B.J.M. Peters and \{Maitland-van der Zee\}, A.H.",

year = "2008",

language = "Undefined/Unknown",

volume = "9",

pages = "1207--1210",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor and Francis",

number = "9",

}

TY - JOUR

T1 - Pharmacogenomic importance of pravastatin

AU - Peters, B.J.M.

AU - Maitland-van der Zee, A.H.

PY - 2008

Y1 - 2008

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1462-2416

VL - 9

SP - 1207

EP - 1210

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 9

ER -